Analysis of early biochemical markers and regulation by tin protoporphyrin IX in a model of spontaneous osteoarthritis

Experimental Gerontology

Volumn 47, Issue 5, 2012, Pages 406-409

  Braza Boïls, Aitana ^a   Ferrándiz, Maria Luisa ^a   Terencio, María Carmen ^a   Alcaraz, María José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Animal model; Biochemical markers; Early detection; Osteoarthritis; STR ort; Tin protoporphyrin IX

Indexed keywords

BIOCHEMICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; PROTOPORPHYRIN TIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EARLY DIAGNOSIS; HISTOPATHOLOGY; KNEE OSTEOARTHRITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TREATMENT DURATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; CLINICAL ENZYME TESTS; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; EARLY DIAGNOSIS; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASE 3; METALLOPORPHYRINS; MICE; MICE, INBRED STRAINS; OSTEOARTHRITIS; PROTOPORPHYRINS;

ANIMALIA; MUS;

EID: 84859856652     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.03.005     Document Type: Article

References (20)

1. Braza-Boils A., Alcaraz M.J., Ferrandiz M.L. Regulation of the inflammatory response by tin protoporphyrin IX in the rat anterior cruciate ligament transection model of osteoarthritis. J. Orthop. Res. 2011, 29:1375-1382.
2. Chambers M.G., Bayliss M.T., Mason R.M. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 1997, 5:301-308.
3. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Jacobs K.M., Van El B., Van Roermund P.M., Bank R.A., Bijlsma J.W., TeKoppele J.M., Lafeber F.P. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 2004, 50:1207-1215.
4. Devesa I., Ferrandiz M.L., Terencio M.C., Joosten L.A., van den Berg W.B., Alcaraz M.J. Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis. Arthritis Rheum. 2005, 52:3230-3238.
5. Di Cesare P.E., Carlson C.S., Stolerman E.S., Hauser N., Tulli H., Paulsson M. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J. Orthop. Res. 1996, 14:946-955.
6. Giunta S. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm. Res. 2008, 57:558-563.
7. Jaeger K., Selent C., Jaehme W., Mahr S., Goebel U., Ibrahim S., Vollmar B., Mueller-Hilke B. The genetics of osteoarthritis in STR/ort mice. Osteoarthritis Cartilage 2008, 16:607-614.
8. Lohmander L.S., Brandt K.D., Mazzuca S.A., Katz B.P., Larsson S., Struglics A., Lane K.A. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum. 2005, 52:3160-3167.
9. Mahr S., Menard J., Krenn V., Muller B. Sexual dimorphism in the osteoarthritis of STR/ort mice may be linked to articular cytokines. Ann. Rheum. Dis. 2003, 62:1234-1237.
10. Mason R.M., Chambers M.G., Flannelly J., Gaffen J.D., Dudhia J., Bayliss M.T. The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthritis Cartilage 2001, 9:85-91.
11. Mistry D., Oue Y., Chambers M.G., Kayser M.V., Mason R.M. Chondrocyte death during murine osteoarthritis. Osteoarthritis Cartilage 2004, 12:131-141.
12. Moroney M.A., Alcaraz M.J., Forder R.A., Carey F., Hoult J.R.S. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J. Pharm. Pharmacol. 1988, 40:787-792.
13. Price J.S., Chambers M.G., Poole A.R., Fradin A., Mason R.M. Comparison of collagenase-cleaved articular cartilage collagen in mice in the naturally occurring STR/ort model of osteoarthritis and in collagen-induced arthritis. Osteoarthritis Cartilage 2002, 10:172-179.
14. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., Salter D., van den Berg W.B. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14:13-29.
15. Sarukawa J., Takahashi M., Doi M., Suzuki D., Nagano A. A longitudinal analysis of urinary biochemical markers and bone mineral density in STR/Ort mice as a model of spontaneous osteoarthritis. Arthritis Rheum. 2010, 62:463-471.
16. Thibault M., Poole A.R., Buschmann M.D. Cyclic compression of cartilage/bone explants in vitro leads to physical weakening, mechanical breakdown of collagen and release of matrix fragments. J. Orthop. Res. 2002, 20:1265-1273.
17. van der Kraan P.M., van den Berg W.B. Osteoarthritis in the context of ageing and evolution. Loss of chondrocyte differentiation block during ageing. Ageing Res. Rev. 2008, 7:106-113.
18. Vilim V., Vytasek R., Olejarova M., Machacek S., Gatterova J., Prochazka B., Kraus V.B., Pavelka K. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage 2001, 9:612-618.
19. Walton M. Degenerative joint disease in the mouse knee; histological observations. J. Pathol. 1977, 123:109-122.
20. Young M.F. Mouse models of osteoarthritis provide new research tools. Trends Pharmacol. Sci. 2005, 26:333-335.